Posts by: Alice Melão

Alice Melão

March 8, 2017

Blincyto Found Superior to Standard Chemotherapy in Advanced ALL Patients, According to Phase 3 Trial

News

Results from a large multinational Phase 3 clinical trial testing the monoclonal antibody Blincyto (blinatumomab) showed that it is more effective than standard chemotherapy for treatment of relapsed or refractory ... Read more

March 2, 2017

Key Protein Identified for Initiating Immune Response Against Cancer Cells, Foreign Pathogens

News

Researchers have identified an enzyme called IFI16 whose expression is key for immune cells to detect danger and initiate an immune response. The findings have the potential to improve immunotherapies ... Read more

February 24, 2017

Study Shows How Protein IFNAR1 Helps Solid Tumors Resist Immunotherapies

News

Despite advances made in cancer treatment, in particular the development of effective immunotherapies, many solid tumors are still resistant. The reason for that may be a protein called IFNAR1, which ... Read more

January 4, 2017January 4, 2017

CAR-T Immunotherapy Shows Promise in Aggressive Brain Cancers, Case Study Reports

News

Immunotherapy using genetically modified immune T-cells (CAR-T) to specifically target the glioma-associated marker IL13Rα2 — a gene expression indicative of an aggressive brain tumor — was reported to be a ... Read more

December 6, 2016December 6, 2016

Findings on ‘Solid Stress’ in Tumors Could Spark Development of New Therapies

News

A study published in the first issue of the scientific journal Nature Biomedical Engineering has described new tools that enables researchers to determine the force exerted by the different solid components of ... Read more

October 6, 2016

Experimental Immunotherapy May Slow Parkinson’s Disease Progression, Researchers Say

News

Toxic aggregates of the alpha-synuclein protein, which are known to cause Parkinson’s disease, can spread from one brain cell to the other, causing the disease to progress. In a new study, ... Read more